United Therapeutics Corporation (FRA:UTH)

United Therapeutics Statistics

Total Valuation

FRA:UTH has a market cap or net worth of EUR 17.78 billion. The enterprise value is 14.05 billion.

Market Cap	17.78B
Enterprise Value	14.05B

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	43.06M
Shares Outstanding	n/a
Shares Change (YoY)	-1.38%
Shares Change (QoQ)	-2.07%
Owned by Insiders (%)	1.79%
Owned by Institutions (%)	93.25%
Float	40.05M

Valuation Ratios

The trailing PE ratio is 16.40 and the forward PE ratio is 14.55.

PE Ratio	16.40
Forward PE	14.55
PS Ratio	6.67
PB Ratio	3.16
P/TBV Ratio	3.22
P/FCF Ratio	18.59
P/OCF Ratio	13.40
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.13, with an EV/FCF ratio of 14.69.

EV / Earnings	12.96
EV / Sales	5.22
EV / EBITDA	10.13
EV / EBIT	10.73
EV / FCF	14.69

Financial Position

The company has a current ratio of 6.40

Current Ratio	6.40
Quick Ratio	5.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	62.62

Financial Efficiency

Return on equity (ROE) is 20.04% and return on invested capital (ROIC) is 14.53%.

Return on Equity (ROE)	20.04%
Return on Assets (ROA)	13.14%
Return on Invested Capital (ROIC)	14.53%
Return on Capital Employed (ROCE)	22.36%
Revenue Per Employee	2.04M
Profits Per Employee	830,552
Employee Count	1,305
Asset Turnover	0.43
Inventory Turnover	2.21

Taxes

In the past 12 months, FRA:UTH has paid 336.40 million in taxes.

Income Tax	336.40M
Effective Tax Rate	23.69%

Stock Price Statistics

The stock price has increased by +15.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+15.47%
50-Day Moving Average	383.50
200-Day Moving Average	302.15
Relative Strength Index (RSI)	71.97
Average Volume (20 Days)	12

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.28

Income Statement

In the last 12 months, FRA:UTH had revenue of EUR 2.67 billion and earned 1.08 billion in profits. Earnings per share was 22.48.

Revenue	2.67B
Gross Profit	2.36B
Operating Income	1.30B
Pretax Income	1.42B
Net Income	1.08B
EBITDA	1.37B
EBIT	1.30B
Earnings Per Share (EPS)	22.48

Balance Sheet

The company has 2.36 billion in cash and n/a in debt, giving a net cash position of 3.69 billion.

Cash & Cash Equivalents	2.36B
Total Debt	n/a
Net Cash	3.69B
Net Cash Per Share	n/a
Equity (Book Value)	5.62B
Book Value Per Share	130.92
Working Capital	2.51B

Cash Flow

In the last 12 months, operating cash flow was 1.33 billion and capital expenditures -370.15 million, giving a free cash flow of 956.20 million.

Operating Cash Flow	1.33B
Capital Expenditures	-370.15M
Free Cash Flow	956.20M
FCF Per Share	n/a

Margins

Gross margin is 88.59%, with operating and profit margins of 48.64% and 40.65%.

Gross Margin	88.59%
Operating Margin	48.64%
Pretax Margin	53.27%
Profit Margin	40.65%
EBITDA Margin	51.28%
EBIT Margin	48.64%
FCF Margin	35.86%

Dividends & Yields

FRA:UTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.38%
Shareholder Yield	1.38%
Earnings Yield	6.10%
FCF Yield	5.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 23, 2009. It was a forward split with a ratio of 2.

Last Split Date	Sep 23, 2009
Split Type	Forward
Split Ratio	2

Scores

FRA:UTH has an Altman Z-Score of 15.06 and a Piotroski F-Score of 6.

Altman Z-Score	15.06
Piotroski F-Score	6